Why the study?
Does simplifying treatment regimens improve adherence and clinical outcomes in hypertensive patients?
Does simplifying treatment regimens improve adherence and clinical outcomes in hypertensive patients?
Simplifying antihypertensive regimens with fixed-dose combinations and long-acting agents is recommended to improve medication adherence and cardiovascular outcomes.
Emphasizes routine adherence checks in hypertension; leaves open whether simplification improves outcomes in randomized trials.
Suboptimal adherence to antihypertensive treatment is very common and is associated with poor control of blood pressure and increased risk for cardiovascular events. Therefore, frequent evaluation of compliance is essential in all hypertensive patients. Simplifying treatment regimens, using fixed-dose combinations and long-acting agents improves adherence, facilitates achievement of treatment targets and reduces cardiovascular morbidity and healthcare expenditures. Accordingly, physicians should be educated to implement these changes in hypertensive patients, particularly in those who require multiple antihypertensive agents to achieve blood pressure controls and in those who receive additional medications for comorbidities.
No takes yet. Share an insight, caveat, or question.
Alkagiet et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: